@speculator101 - it sounds like CAS is a stone in your shoe. Get rid of it lol. You can use the cash to make profits elsewhere and spend less mental capital on this.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025